Company / Operating Income
Relay Therapeutics, Inc. Operating Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$302.7M
FY2025
5-year range
-$373.0M / -$55.8M
FY2021-FY2025
Trend
+18.7%
vs FY2024
Sector context
#164 of 204
Health Care
What the data says
Relay Therapeutics, Inc.'s operating income of -$303M is lower than 80% of companies in the Health Care sector (FY2025). Improved from -$373M to -$303M over the past 2 years.
Based on SEC 10-K filings.
-$303M in FY2025.
Improved from -$373M to -$303M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 204This company -$302.7M Sector average $107.8M
▼
-381.0% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 18.7% year-over-year.
- Ranks #164 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2022.
- Lowest operating income in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$302.7M | +18.7% |
| FY2024 | -$372.5M | +0.1% |
| FY2023 | -$373.0M | -568.5% |
| FY2022 | -$55.8M | +33.6% |
| FY2021 | -$84.0M | +0.0% |
| FY2020 | -$84.0M | +0.0% |
| FY2019 | -$84.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026